medigraphic.com

2006, Number S2

<< Back Next >>

Arch Cardiol Mex 2006; 76 (S2)

Molecular aspect of systemic arterial hypertension

Meaney E

Language: Spanish
References: 23
Page: 170-175
PDF size: 93.81 Kb.


ABSTRACT

Some genetic issues of hypertensive diseases are discussed, as well as some benefits of the study of these aspects in the clinical management of high blood pressure. Some characteristics of hypertension as a “civilization disease” are pointed out, particularly the combination of pathogenic genetic and environmental mechanisms. Interactions among genes and environment are described as well as rare examples of monogenic hypertension. Some genes with hypertensive action potential are mentioned. It is difficult to establish the connection among the polymorphisms and the development of hypertension or its complications and consequences. It is underlined the urgent need to establish the true importance of these already known polymorphisms, and other still undisclosed, in the Mexican population.


REFERENCES

  1. GINSBURG GS, DONAHUE MP, NEWBY LK: Prospects of personalized cardiovascular medicine. The impact of genomics. J Amer Coll Cardiol 2005; 46: 1615-1627.

  2. FORNAGE M, DORIS PA: Use of single nucleotide polymorphisms for gene discovery in hypertension. Curr Hypertens Rep 2000; 2: 23-31.

  3. DORIS PA: Hypertension genetics, single nucleotide polymorphism, and the common disease: common variant hypothesis. Hypertension 2002; 39: 323-329.

  4. FOLKOW B: The Fourth Volhard Lecture. Cardiovascular structural adaptation: its role in the initiation and maintenance of primary hypertension. Clin Sci Mol Med 1978; 56: 3-19.

  5. KATO N, JULIER C: Linkage mapping for hypertension susceptibility genes. Curr Hypertension Rep 1999; 1: 15-24.

  6. RICH N: Linkage strategies for generically complex traits. [II. The power of affected relative sibling pairs]. Am J Hum Genet 1990; 46: 229-241.

  7. KHOURY MJ, ADAMS MJ, FLANDERS WD: An epidemiologic approach to ecogenetics. Am J Hum Genet 1988; 42: 89-95.

  8. PAUSOVA Z, TREMBLAY J, HAMET P: Gene-environment interactions in hypertension. Curr Hypertens Curr 1999; 1: 42-50.

  9. TANIRA MOM, BALUSHI KA AL: Genetic variations related to hypertension: a review. J Human Hypertens 2005; 19: 7-19.

  10. KARDIA SLR: Context-dependent genetic effects in hypertension. Curr Hypertens Rep 2000; 2: 32-38. 11. KAMITAMINI A, WONG ZYH, FRASER D, DAVIES DL, CONNOR JM, FOY CJW, ET AL: Human α-adducing gene, blood pressure and sodium metabolism. Hypertension 1998; 32: 138-143.

  11. TAKANI S, IMAI Y, KATSUYA T, OHKUBO T, TSUJI I, NAGAI K, ET AL: Gene polymorphism of the reninangiotensin system associates with risk for lacunar infarction. The Ohasama Study. Am J Hypertens 2000; 13: 121-127.

  12. BUSJAHN A, KNOBLAUCH H, KNOBLAUCH M, BOHLENDER J, MENZ M, FAULHABER H-D, ET AL: Angiotensin-converting enzyme and angiotensin gene polymorphisms, plasma levels, cardiac dimensions. A twin study. Hypertension 1997; 29: 165-170.

  13. JEUNEMAITRE X, GIMENEZ-ROQUEPLO A-P, CÉLÉRIER J, CORVOL P: Angiotensin variants and human hypertension. Curr Hypertens Rep 1999; 1: 31-41.

  14. SETHI AA: Angiotensin gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease. Arterioscler Thromb Vasc Biol 2003; 23: 1269-1275.

  15. LINDPAINTNER K, PFEFFER MA, KREUTZ R, STAMPFER MJ, GRODSTEIN F, LAMOTTE F, ET AL: A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995; 332: 706-711.

  16. CAMBIEN F, POIRIER O, LECERF L, EVANS A, CAMBOU J, ARVELIER D, ET AL: Deletion polymorphism in the gene of angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-644.

  17. SCHIEFFER B, DREXLER H: (editorial). ACE gene polymorphism and coronary artery disease. A question of persuasion or statistical confusion. Arterioscler Thromb Vasc Biol 2000; 20: 281-282.

  18. DANSER AH, SCHALEKAMP MA, BAX WA, VAN DEN BRINK AM, SAXENA PR, RIEGGER GA, ET AL: Angiotensin-converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation 1995; 92: 1387-1388.

  19. SIFFERT W: G-protein beta3 subunit 825 T allele and hypertension. Curr Hypertens Rep 2003; 5: 47-53.

  20. TIMMERMANN B, RUNE MO, LUFT FC, GERDTS E, BUSJAHN A, OMVIK P, ET AL: β-2 Adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressures Study. Kidney International 1998; 53: 1455-1460.

  21. GRANT FD, ROMERO JR, JEUNEMAITRE X, HUNT SC, HOPKINS PN, HOLLENBERG NH, ET AL: Low-renin hypertension, altered sodium homeostasis and an α-adducin polymorphism. Hypertension 2002; 39: 191-196.

  22. SHIN M-H, CHUNG E-K, KIM H-N, PARK K-S, NAM H-S, KWEON S-S, ET AL. Alpha- adducin Gly 460 Trp polymorphism in essential hypertension in Korea. J Korean Med Sci 2004; 19: 812-814.

  23. CLARK CJ, DAVIES E, ANDERSON NH, FARMER R, FRIEL EC, FRASER R, ET AL: α-adducin and angiotensin I-converting enzyme polymorphisms in essential hypertension. Hypertension 2000; 36: 990-994.




2020     |     www.medigraphic.com